NCT06947512 Personalization of Visual Characters and Text-to-Speech (TTS) to Support Learning in Students With Reading Difficulties
| NCT ID | NCT06947512 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Eugenio Medea |
| Condition | Developmental Dyslexia |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2023-02-16 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2023-02-16 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Previous research has shown the importance of font type, size and spacing to facilitate text reading in dyslexia. A special automatized procedure was designed to select the most favorable parameters for both text visualization and text-to-speech (TTS) conversion to be used by students with reading difficulties. The validation of its outcomes will be carried out through a systematic comparison of the use of the personalized versus standard fonts and voices in reading and writing tests.
Eligibility Criteria
Inclusion Criteria (for TD group): * age 7-15 years * no history of reading difficulties * attends school in Italy Exclusion Criteria (for TD group): * special educational needs or diagnosis of neurodevelopmental disorders Inclusion Criteria (for DD group): * age 7-15 years * diagnosis of Developmental Dyslexia or Specific Reading Disorder * Attends school in Italy Exclusion Criteria (for DD group): * diagnosis of Intellectual Disability Inclusion Criteria (for SEN group): * age 7-15 years * reported by school to have significant difficulties in reading and writing * Attends school in Italy (at least 6 months continued schooling and exposure to the Italian language) Exclusion Criteria (for SEN group): * diagnosis of Intellectual Disability
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06947512 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 15 Years, studying Developmental Dyslexia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06947512 currently recruiting?
Yes, NCT06947512 is actively recruiting participants. Contact the research team at marialuisa.lorusso@lanostrafamiglia.it for enrollment information.
Where is the NCT06947512 trial being conducted?
This trial is being conducted at Bosisio Parini, Italy, Conegliano, Italy, Treviso, Italy.
Who is sponsoring the NCT06947512 clinical trial?
NCT06947512 is sponsored by IRCCS Eugenio Medea. The trial plans to enroll 90 participants.